'Very knowledgeable, supportive and responsive', Fieldfisher‘s life sciences team is well placed to advise on funding and transactions for pharma product development and programmes, as well as regulatory matters concerning new technologies and development. The team is led by ’industry veteran’ Janita Good, a transactional lawyer experienced in corporate and IP partnering deals, with specific expertise in complex structuring and M&A exits. Sarah Ellson draws on her public law experience to advise on regulatory and compliance matters, supporting market entrants navigating the regulatory landscape. Sarah Tedstone is an expert in health data privacy and compliance. John Linneker is no longer at the firm.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
‘Very knowledgeable, supportive and responsive. They give clear advice.’
'Janita Good is a longstanding industry veteran with extensive experience advising on both corporate and IP transfer matters. She understands her clients' businesses and is a trusted adviser to them. Overall, the firm has a very strong focus on life sciences and leverages its IP expertise to also advise on transactional matters.'
Key clients
- Novartis
- CRISM Therapeutics Corporation and CRISM Therapeutics Limited
Work highlights
Advised Novartis Pharma AG on a global project involving managing external Counsel identifying the local regulations and legislation in relation to Patient Support Programmes (PSPs) in over 38 countries.
Practice head
Janita Good
Other key lawyers
Sarah Ellson; Sarah Tedstone; Sonal Patel Oliva; Vicky Reinhardt